30,593 Baxter International Inc. $BAX Shares Acquired by Sterling Capital Management LLC

Sterling Capital Management LLC grew its holdings in Baxter International Inc. (NYSE:BAX) by 197.9% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 46,051 shares of the medical instruments supplier’s stock after acquiring an additional 30,593 shares during the period. Sterling Capital Management LLC’s holdings in Baxter International were worth $1,105,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. BlackRock Inc. purchased a new position in Baxter International in the second quarter valued at about $1,744,874,000. Pzena Investment Management LLC purchased a new stake in shares of Baxter International in the second quarter worth about $1,392,098,000. Equity Investment Corp purchased a new stake in shares of Baxter International in the second quarter worth about $146,815,000. Bank of America Corp DE purchased a new stake in shares of Baxter International in the second quarter worth about $132,993,000. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Baxter International in the second quarter valued at about $68,036,000. Institutional investors and hedge funds own 90.19% of the company’s stock.

Baxter International Stock Down 0.0%

Shares of NYSE BAX opened at $25.30 on Tuesday. Baxter International Inc. has a 1 year low of $15.73 and a 1 year high of $30.00. The firm has a market cap of $13.08 billion, a price-to-earnings ratio of -12.22, a PEG ratio of 3.83 and a beta of 0.65. The company has a debt-to-equity ratio of 1.39, a quick ratio of 1.32 and a current ratio of 1.95. The stock’s 50-day simple moving average is $24.77 and its 200-day simple moving average is $21.27.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.19. Baxter International had a positive return on equity of 16.57% and a negative net margin of 9.27%. The firm had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $2.80 billion. During the same quarter in the prior year, the business posted $0.59 earnings per share. Baxter International’s revenue for the quarter was up 5.3% on a year-over-year basis. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS. As a group, equities analysts anticipate that Baxter International Inc. will post 2.04 earnings per share for the current fiscal year.

Baxter International Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 1st. Stockholders of record on Friday, August 28th were paid a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, August 28th. Baxter International’s dividend payout ratio is -1.93%.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on BAX shares. Stifel Nicolaus raised their target price on Baxter International from $19.00 to $24.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. UBS Group boosted their price target on Baxter International from $19.00 to $25.00 and gave the stock a “hold” rating in a research report on Tuesday, July 28th. Barclays assumed coverage on Baxter International in a report on Wednesday, October 7th. They issued an “underweight” rating and a $20.00 price target for the company. Zacks Research raised shares of Baxter International from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 11th. Finally, The Goldman Sachs Group lifted their price objective on shares of Baxter International from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and an average price target of $21.73.

About Baxter International

Baxter International Inc is a global medical products and healthcare technology company headquartered in Deerfield, Illinois. The company develops, manufactures and distributes products used in hospitals, clinics, ambulatory care centers and other healthcare settings.

Baxter’s portfolio has included intravenous therapies and administration systems, infusion pumps, connected-care technologies, surgical products, patient monitoring equipment and products used in medication preparation and delivery.